FDA Inspection 1088610 — Montefiore's Institute For Reproductive Medicine And Health

Montefiore's Institute For Reproductive Medicine And Health — FEI 3003972343

The FDA completed an inspection of Montefiore's Institute For Reproductive Medicine And Health on May 3, 2019 in Hartsdale, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 3, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Hartsdale, NY (United States)

Citations

IDCFRDescription
1222121 CFR 1271.47(a)Procedures for all other requirements
1223021 CFR 1271.50(a)Responsible person to determine, document

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.